Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Radioiodine decay-a change in approach to the management of differentiated thyroid cancer.

The British journal of surgery·2025
Same author

A Systematic Review of Absorbed Doses and Response in Patients Treated with Radioiodine for Differentiated Thyroid Cancer.

Thyroid : official journal of the American Thyroid Association·2025
Same author

Systemic Therapy for Advanced Thyroid Cancer-New Personalized Options.

Drugs·2025
Same author

Anaplastic Thyroid Carcinoma: A Contemporary Review of Challenges and Advances.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2025
Same author

Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial.

Lancet (London, England)·2025
Same author

Molecular predictive biomarker testing in advanced thyroid cancer - a European consensus.

European thyroid journal·2025

相关实验视频

Updated: Sep 13, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.5K

在甲状腺髓癌中准RET.

Kate Newbold, Leslie Cheng

    Endocrine-related cancer
    |July 31, 2025
    PubMed
    概括

    甲状腺髓性癌症 (MTC) 治疗已经通过针对RET突变的铁氨酸激酶抑制剂得到了进展. 较新的选择性RET抑制剂提供了更好的疗效和安全性,尽管克服耐药性仍然至关重要.

    科学领域:

    • 在瘤学瘤学.
    • 遗传学 是一个遗传学.
    • 药理学 药理学是指药理学的学科.

    背景情况:

    • 甲状腺髓癌 (MTC) 是一种罕见的内分泌恶性瘤.
    • 在25-65%的MTC病例中发现了RET原基因突变,导致异常的激酶活性.
    • 向疗法已经彻底改变了MTC治疗,特别是在RET突变瘤中.

    研究的目的:

    • 审查MTC治疗的进展情况.
    • 突出氨酸激酶抑制剂在管理MTC中的作用.
    • 讨论从多酶抑制剂到选择性RET抑制剂的演变.

    主要方法:

    • 对MTC治疗方法的临床研究和文献的审查.
    • 分析各种氨酸激酶抑制剂的疗效和副作用概况.
    • 检查针对RET向疗法的作用机制.

    主要成果:

    • 多激酶抑制剂 (万德他尼布,卡博桑提尼布) 在晚期MTC中表现出有效性.
    • 选择性RET抑制剂 (selpercatinib,pralsetinib) 显示出高疗效与改善的安全性.
    • 这些较新的药物减少了非目标效应,提高了患者的治疗结果.
    关键词:
    RET M918TT 的时间RET 抑制剂的使用.骨髓甲状腺癌是一种甲状腺癌.铁氨基激酶抑制剂 铁氨基激酶抑制剂

    更多相关视频

    An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
    07:01

    An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

    Published on: April 17, 2013

    21.2K
    Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
    03:55

    Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

    Published on: June 9, 2023

    623

    相关实验视频

    Last Updated: Sep 13, 2025

    In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
    07:02

    In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

    Published on: August 23, 2019

    7.5K
    An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
    07:01

    An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

    Published on: April 17, 2013

    21.2K
    Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
    03:55

    Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

    Published on: June 9, 2023

    623

    结论:

    • 氨酸激酶抑制剂,特别是选择性RET抑制剂,代表了MTC治疗的重大进展.
    • 目前的治疗方法改善了疾病控制和患者的幸福感.
    • 需要进一步的研究,以解决和克服MTC的治疗耐药性.